Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:January 12, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:January 12, 2024Recruiting
Condition(s):Macular Holes; Epiretinal Membrane; Diabetic Retinopathy; Retinal Detachment; Retinal Disease; Preretinal Fibrosis; Cataract; Ocular Tumor; Strabismus; HealthyLast Updated:July 3, 2023Recruiting
Condition(s):Eye Diseases; Retinitis Pigmentosa; Glaucoma; Diabetic Retinopathy; Macular Degeneration; Traumatic Optic Neuropathy; Optic AtrophyLast Updated:October 27, 2022Recruiting
Condition(s):Retinitis Pigmentosa; Eye Diseases, Hereditary; Retinal Dystrophies; Retinal Dystrophy Rod; Retinal Dystrophy Rod ProgressiveLast Updated:October 18, 2023Recruiting
Condition(s):ColobomaLast Updated:March 21, 2024Recruiting
Condition(s):Age-Related Macular DegenerationLast Updated:January 22, 2024Recruiting
Condition(s):Retinal Angiomatous ProliferationLast Updated:August 22, 2022Recruiting
Condition(s):Macular HolesLast Updated:December 14, 2023Not yet recruiting
Condition(s):Fetal HemoglobinLast Updated:March 29, 2023Not yet recruiting
Condition(s):Age-Related Macular DegenerationLast Updated:February 9, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.